CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

CME Credit Available: This activity offers a total of 37.25 hours of AOA Category 1A credits and AMA PRA Category 1 Credits™. Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: • Revise and refresh knowledge of core topics in internal medicine and the subspecialties through discussion of common and uncommon clinical problems. • Apply successful strategies to respond to challenging scenarios. • Synthesize and implement changes in clinical practice in accordance with recent advances, guidelines, and evidence-based practice.

CME Credit Available: This lecture is under 10 minutes and therefore, does not qualify for CME credit. Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • The appearance of different inclusions found in synovial fluid. • The group types of synovial fluid. • The types of disease seen in the different types of synovial fluid.

CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

NON-CME Sponsored by AstraZeneca.

#ACOI2023 Annual Convention & Scientific Sessions is the learning experience for osteopathic internists and subspecialists, residents, and students featuring innovative keynote speakers, unique networking opportunities, and the latest advances in subspecialty topics, practice management, and faculty development. CME Credit Available: This activity offers a total of 46.50 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter.

Completion of this activity will allow learners to define basic climate principles; identify major climate trends; identify climate impacts on human health; and relate health inequity to climate impacts. This activity is worth 1.00 AOA Category 1B Credit.